Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Синдром обструктивного апноэ во сне и менопаузальный переход
Синдром обструктивного апноэ во сне и менопаузальный переход
Кузнецов1 Д.И., Кузнецова2 И.В. Синдром обструктивного апноэ во сне и менопаузальный переход. Consilium Medicum. 2013; 15 (6): 18–24.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Genazzani AR, Gambacciani M, Simoncini T. Menopause and aging, quality of life and sexuality. Climacteric 2007;10(2): 88–96.
2. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142(12 Pt 1): 1003–13.
3. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007; 14(5): 826–9.
4. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28(3): 596–602.
5. Arzt M, Young T, Finn L et al. TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172(11): 1447–51.
6. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006; 166(16): 1709–15.
7. Young T, Finn L, Peppard PE et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. SLEEP 2008; 31(8): 1071–8.
8. Ray KK, Seshasai SRK, Erqou S et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010; 170(12): 1024–31.
9. Culver AL, Ockene IS, Balasubramanian R et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med 2012; 172(2): 144–52.
10. Aging, menopause, cardiovascular disease and HRT. International Menopause Society Consensus Statement. Climacteric 2009; 12(5): 368–77.
11. Block AJ, Boysen PG, Wynne JW, Hunt LA. Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance. N Engl J Med 1979; 300(10): 513–7.
12. Young T, Palta M, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17): 1230–5.
13. Mohsenin V. Effects of gender on upper airway collapsibility and severity of obstructive sleep apnea. Sleep Med 2003; 4(6): 523–9.
14. Rowley JA, Zhou X, Vergine I et al. Influence of gender on upper airway mechanics: upper airway resistance and Pcrit. J Appl Physiol 2001; 91(5): 2248–54.
15. Tatsumi K, Pickett CK, Jacoby CR et al. Role of endogenous female hormones in hypoxic chemosensitivity. J Appl Physiol 1997; 83(5): 1706–10.
16. Takano N. Change in time course of posthyperventilation hyperpnea during menstrual cycle. J Appl Physiol 1988; 64(6): 2631–5.
17. Jordan AS, Eckert DJ, Catcheside PG, McEvoy RD. Ventilatory response to brief arousal from non-rapid eye movement sleep is greater in men than in women. Am J Respir Crit Care Med 2003; 168(12): 1512–9.
18. Joffe H, Massler A, Sharkey KM. Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med 2010; 28(5): 404–21.
19. Bixler EO, Vgontzas AN, Lin HM et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163(3 Pt 1): 608–13.
20. Block AJ, Wynne JW, Boysen PG. Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women. Am J Med 1980; 69(1): 75–9.
21. Paul KN, Turek FW, Kryger MH. Influence of sex on sleep regulatory mechanisms. J Womens Health (Larchmt) 2008; 17(7): 1201–8.
22. Mong JA, Devidze N, Goodwillie A, Pfaff DW. Reduction of lipocalin-type prostaglandin D synthase in the preoptic area of female mice mimics estradiol effects on arousal and sex behavior. Proc Natl Acad Sci U S A 2003; 100(25): 15206–11.
23. Балан В.Е., Юренева С.В., Сметник В.П., Сметник Л.М. Кардиометаболические расстройства у женщин в постменопаузе: негативная роль андрогенов с позиций доказательной медицины. Проблемы репродукции. 2012; 3: 7–15.
24. Will MA, Randolph JF. The influence of reproductive hormones on brain function in the menopausal transition. Minerva Ginecol 2009; 61(6): 469–81.
25. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88(6): 2404–11.
26. Otsuki M, Kasayama S, Morita S, et al. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause 2007; 14(3 Pt 1): 404–7.
27. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine 2006; 23(5): 469–80.
28. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291(16): 2013–6.
29. Dursunoglu N, Ozkurt S, Sarikaya S. Is the clinical presentation different between men and women admitting to the sleep laboratory? Sleep Breath 2009; 13(3): 295–8.
30. Resta O, Carpanano GE, Lacedonia D, et al. Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA). Respir Med 2005; 99(1): 91–6.
31. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. SLEEP 2005; 28(3): 309–14.
32. Guilleminault C, Palombini L, Poyares D, Chowdhuri S. Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res 2002; 53(1): 611–5.
33. Shahar E, Redline S, Young T et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003; 167(9): 1186–92.
34. Pickett CK, Regensteiner JG, Woodard WD et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989; 66(4): 1656–61.
35. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999; 6(3): 196–200.
36. Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. SLEEP 2003; 26(2): 163–8.
37. Saletu-Zyhlarz G, Anderer P, Gruber G et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003; 12(3): 239–54.
38. Polo-Kantola P, Rauhala E, Helenius H et al. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 2003; 102(1): 68–75.
39. Hachul H, Bittencourt LRA, Andersen ML et al. Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int J Gynaecol Obstet 2008; 103(3): 207–12.
40. Schussler P, Kluge M, Yassouridis A et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology 2008; 33(8): 1124–31.
41. Gambacciani M, Ciaponi M, Cappagli B et al. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas 2005; 50(2): 91–7.
2. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142(12 Pt 1): 1003–13.
3. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007; 14(5): 826–9.
4. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28(3): 596–602.
5. Arzt M, Young T, Finn L et al. TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172(11): 1447–51.
6. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006; 166(16): 1709–15.
7. Young T, Finn L, Peppard PE et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. SLEEP 2008; 31(8): 1071–8.
8. Ray KK, Seshasai SRK, Erqou S et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010; 170(12): 1024–31.
9. Culver AL, Ockene IS, Balasubramanian R et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med 2012; 172(2): 144–52.
10. Aging, menopause, cardiovascular disease and HRT. International Menopause Society Consensus Statement. Climacteric 2009; 12(5): 368–77.
11. Block AJ, Boysen PG, Wynne JW, Hunt LA. Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance. N Engl J Med 1979; 300(10): 513–7.
12. Young T, Palta M, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17): 1230–5.
13. Mohsenin V. Effects of gender on upper airway collapsibility and severity of obstructive sleep apnea. Sleep Med 2003; 4(6): 523–9.
14. Rowley JA, Zhou X, Vergine I et al. Influence of gender on upper airway mechanics: upper airway resistance and Pcrit. J Appl Physiol 2001; 91(5): 2248–54.
15. Tatsumi K, Pickett CK, Jacoby CR et al. Role of endogenous female hormones in hypoxic chemosensitivity. J Appl Physiol 1997; 83(5): 1706–10.
16. Takano N. Change in time course of posthyperventilation hyperpnea during menstrual cycle. J Appl Physiol 1988; 64(6): 2631–5.
17. Jordan AS, Eckert DJ, Catcheside PG, McEvoy RD. Ventilatory response to brief arousal from non-rapid eye movement sleep is greater in men than in women. Am J Respir Crit Care Med 2003; 168(12): 1512–9.
18. Joffe H, Massler A, Sharkey KM. Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med 2010; 28(5): 404–21.
19. Bixler EO, Vgontzas AN, Lin HM et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163(3 Pt 1): 608–13.
20. Block AJ, Wynne JW, Boysen PG. Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women. Am J Med 1980; 69(1): 75–9.
21. Paul KN, Turek FW, Kryger MH. Influence of sex on sleep regulatory mechanisms. J Womens Health (Larchmt) 2008; 17(7): 1201–8.
22. Mong JA, Devidze N, Goodwillie A, Pfaff DW. Reduction of lipocalin-type prostaglandin D synthase in the preoptic area of female mice mimics estradiol effects on arousal and sex behavior. Proc Natl Acad Sci U S A 2003; 100(25): 15206–11.
23. Балан В.Е., Юренева С.В., Сметник В.П., Сметник Л.М. Кардиометаболические расстройства у женщин в постменопаузе: негативная роль андрогенов с позиций доказательной медицины. Проблемы репродукции. 2012; 3: 7–15.
24. Will MA, Randolph JF. The influence of reproductive hormones on brain function in the menopausal transition. Minerva Ginecol 2009; 61(6): 469–81.
25. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88(6): 2404–11.
26. Otsuki M, Kasayama S, Morita S, et al. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause 2007; 14(3 Pt 1): 404–7.
27. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine 2006; 23(5): 469–80.
28. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291(16): 2013–6.
29. Dursunoglu N, Ozkurt S, Sarikaya S. Is the clinical presentation different between men and women admitting to the sleep laboratory? Sleep Breath 2009; 13(3): 295–8.
30. Resta O, Carpanano GE, Lacedonia D, et al. Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA). Respir Med 2005; 99(1): 91–6.
31. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. SLEEP 2005; 28(3): 309–14.
32. Guilleminault C, Palombini L, Poyares D, Chowdhuri S. Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res 2002; 53(1): 611–5.
33. Shahar E, Redline S, Young T et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003; 167(9): 1186–92.
34. Pickett CK, Regensteiner JG, Woodard WD et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989; 66(4): 1656–61.
35. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999; 6(3): 196–200.
36. Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. SLEEP 2003; 26(2): 163–8.
37. Saletu-Zyhlarz G, Anderer P, Gruber G et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003; 12(3): 239–54.
38. Polo-Kantola P, Rauhala E, Helenius H et al. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 2003; 102(1): 68–75.
39. Hachul H, Bittencourt LRA, Andersen ML et al. Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int J Gynaecol Obstet 2008; 103(3): 207–12.
40. Schussler P, Kluge M, Yassouridis A et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology 2008; 33(8): 1124–31.
41. Gambacciani M, Ciaponi M, Cappagli B et al. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas 2005; 50(2): 91–7.
Авторы
Д.И.Кузнецов1, И.В.Кузнецова2
1. ФГБУ Эндокринологический научный центр Минздрава РФ;
2. ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ
1. ФГБУ Эндокринологический научный центр Минздрава РФ;
2. ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.
